Clinical Scientist, Medicines Development & Strategy

Grifols; Dublin; On-site; EUR 90,000 - 120,000; Full time

Benefits offered by this job

A highly competitive salary package

Group pension scheme

Private medical insurance for the e m

Ongoing career development

Succession planning

Education and professional development

Wellness and social initiatives

Job summary

Grifols is seeking a Clinical Scientist to contribute to scientific strategies for new indications and to evaluate literature for regulatory documents. The role supports MDs with clinical inquiries, ongoing trials, risk evaluation, safety narratives, and advisory boards to ensure smooth regulatory and trial processes.

You will build clinical protocols, review study literature, and collaborate with Medicines Development/Evidence Generation groups to advance program development across indications

Qualifications

• Experience in pharmaceutical/medicine development.
• Strong understanding of GCP and ICH regulations.
• Ability to synthesize literature for study designs and regulatory documents.
• Experience supporting advisory boards and regulatory submissions.

Responsibilities

• Develop scientific strategies for new indications and review literature to support regulatory documents.
• Support MDs with clinical enquiries, ongoing trials, risk evaluation and safety narratives.
• Contribute to study design, protocols, and regulatory dossiers with cross-functional teams.
• Assist in responding to clinical questions from countries and coordinating with global teams.

Skills

Clinical trial experience

Regulatory understanding

Data interpretation

Communication with MDs

Education

Master's degree

PhD

Job description

Grifols is seeking a Clinical Scientist to contribute to scientific strategies for new indications and to evaluate literature for regulatory documents. The role supports MDs with clinical inquiries, ongoing trials, risk evaluation, safety narratives, and advisory boards to ensure smooth regulatory and trial processes.

You will build clinical protocols, review study literature, and collaborate with Medicines Development/Evidence Generation groups to advance program development across indications